BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 31331383)

  • 1. In silico investigation of mitragynine and 7-hydroxymitragynine metabolism.
    Limpanuparb T; Noorat R; Tantirungrotechai Y
    BMC Res Notes; 2019 Jul; 12(1):451. PubMed ID: 31331383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of in vitro absorption, distribution, metabolism, and excretion (ADME) properties of mitragynine, 7-hydroxymitragynine, and mitraphylline.
    Manda VK; Avula B; Ali Z; Khan IA; Walker LA; Khan SI
    Planta Med; 2014 May; 80(7):568-76. PubMed ID: 24841968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolite profiling and identification of enzymes responsible for the metabolism of mitragynine, the major alkaloid of
    Kamble SH; Sharma A; King TI; León F; McCurdy CR; Avery BA
    Xenobiotica; 2019 Nov; 49(11):1279-1288. PubMed ID: 30547698
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development, validation, and application of an LC-MS/MS method for mitragynine and 7-hydroxymitragynine analysis in hair.
    Meier U; Mercer-Chalmers-Bender K; Scheurer E; Dussy F
    Drug Test Anal; 2020 Feb; 12(2):280-284. PubMed ID: 31833662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of metabolites and potential biomarkers of kratom in urine.
    Basiliere S; Kerrigan S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Mar; 1140():121971. PubMed ID: 32058315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on the metabolism of mitragynine, the main alkaloid of the herbal drug Kratom, in rat and human urine using liquid chromatography-linear ion trap mass spectrometry.
    Philipp AA; Wissenbach DK; Zoerntlein SW; Klein ON; Kanogsunthornrat J; Maurer HH
    J Mass Spectrom; 2009 Aug; 44(8):1249-61. PubMed ID: 19536806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of three chromatographic techniques for the detection of mitragynine and other indole and oxindole alkaloids in Mitragyna speciosa (kratom) plants.
    Wang M; Carrell EJ; Ali Z; Avula B; Avonto C; Parcher JF; Khan IA
    J Sep Sci; 2014 Jun; 37(12):1411-8. PubMed ID: 24659356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suspected Adulteration of Commercial Kratom Products with 7-Hydroxymitragynine.
    Lydecker AG; Sharma A; McCurdy CR; Avery BA; Babu KM; Boyer EW
    J Med Toxicol; 2016 Dec; 12(4):341-349. PubMed ID: 27752985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A validated method for the quantification of mitragynine in sixteen commercially available Kratom (Mitragyna speciosa) products.
    Fowble KL; Musah RA
    Forensic Sci Int; 2019 Jun; 299():195-202. PubMed ID: 31059866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism studies of the Kratom alkaloid speciociliatine, a diastereomer of the main alkaloid mitragynine, in rat and human urine using liquid chromatography-linear ion trap mass spectrometry.
    Philipp AA; Wissenbach DK; Weber AA; Zapp J; Maurer HH
    Anal Bioanal Chem; 2011 Mar; 399(8):2747-53. PubMed ID: 21249338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic and Receptor Signaling Explorations of the Mitragyna Alkaloids: Mitragynine as an Atypical Molecular Framework for Opioid Receptor Modulators.
    Kruegel AC; Gassaway MM; Kapoor A; Váradi A; Majumdar S; Filizola M; Javitch JA; Sames D
    J Am Chem Soc; 2016 Jun; 138(21):6754-64. PubMed ID: 27192616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human Mitragynine and 7-Hydroxymitragynine Pharmacokinetics after Single and Multiple Daily Doses of Oral Encapsulated Dried Kratom Leaf Powder.
    Huestis MA; Brett MA; Bothmer J; Atallah R
    Molecules; 2024 Feb; 29(5):. PubMed ID: 38474495
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic and Pharmacodynamic Consequences of Cytochrome P450 3A Inhibition on Mitragynine Metabolism in Rats.
    Kamble SH; Obeng S; León F; Restrepo LF; King TI; Berthold EC; Kanumuri SRR; Gamez-Jimenez LR; Pallares VLC; Patel A; Ho NP; Hampson A; McCurdy CR; McMahon LR; Wilkerson JL; Sharma A; Hiranita T
    J Pharmacol Exp Ther; 2023 Jun; 385(3):180-192. PubMed ID: 37019472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the rewarding effects of mitragynine and 7-hydroxymitragynine in an intracranial self-stimulation procedure in male and female rats.
    Behnood-Rod A; Chellian R; Wilson R; Hiranita T; Sharma A; Leon F; McCurdy CR; McMahon LR; Bruijnzeel AW
    Drug Alcohol Depend; 2020 Oct; 215():108235. PubMed ID: 32889450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase I and II metabolites of speciogynine, a diastereomer of the main Kratom alkaloid mitragynine, identified in rat and human urine by liquid chromatography coupled to low- and high-resolution linear ion trap mass spectrometry.
    Philipp AA; Wissenbach DK; Weber AA; Zapp J; Maurer HH
    J Mass Spectrom; 2010 Nov; 45(11):1344-57. PubMed ID: 20967737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism studies of the Kratom alkaloids mitraciliatine and isopaynantheine, diastereomers of the main alkaloids mitragynine and paynantheine, in rat and human urine using liquid chromatography-linear ion trap-mass spectrometry.
    Philipp AA; Wissenbach DK; Weber AA; Zapp J; Maurer HH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 May; 879(15-16):1049-55. PubMed ID: 21450536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An accidental poisoning with mitragynine.
    Karinen R; Fosen JT; Rogde S; Vindenes V
    Forensic Sci Int; 2014 Dec; 245():e29-32. PubMed ID: 25453780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lateral Flow Assessment and Unanticipated Toxicity of Kratom.
    Smith LC; Lin L; Hwang CS; Zhou B; Kubitz DM; Wang H; Janda KD
    Chem Res Toxicol; 2019 Jan; 32(1):113-121. PubMed ID: 30380840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Trouble With Kratom: Analytical and Interpretative Issues Involving Mitragynine.
    Papsun DM; Chan-Hosokawa A; Friederich L; Brower J; Graf K; Logan B
    J Anal Toxicol; 2019 Sep; 43(8):615-629. PubMed ID: 31424079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactive Effects of
    Obeng S; Leon F; Patel A; Zuarth Gonzalez JD; Chaves Da Silva L; Restrepo LF; Gamez-Jimenez LR; Ho NP; Guerrero Calvache MP; Pallares VLC; Helmes JA; Shiomitsu SK; Soto PL; McCurdy CR; McMahon LR; Wilkerson JL; Hiranita T
    J Pharmacol Exp Ther; 2022 Dec; 383(3):182-198. PubMed ID: 36153006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.